GRI Index

Transcription

GRI Index
1
GRI INDEX
This report is aligned with the Global Reporting Initiative (GRI) G3.1
Sustainability Reporting Guidelines, at an application level of B+.
To locate the elements and information contained within the
guidelines, use the index below.
Key
FULLy Reported
PARTIAL Reported
Standard disclosures part i: profile disclosures
Profile
disclosure
Disclosure
Level of
reporting
Location of disclosure
Page
1. Strategy and analysis
1.1
Statement from the most senior decision-maker of the organization.
2012 CSR Report – Introduction,
Senior management interview
3
1.2
Description of key impacts, risks, and opportunities.
2012 CSR Report – Introduction,
Senior management interview
3
2012 CSR Report – Introduction,
About CSR at Sanofi
6
2012 CSR Report – Introduction,
Our material issues
7
2. Organisational profile
2.1
Name of the organization.
2.2
Primary brands, products, and/or services.
Our products (http://en.sanofi.com/
products/products.aspx),
Form 20-F 2012 – Part I - Item 4
- ((http://en.sanofi.com/investors/
news/news.aspx)
20-21
2.3
Operational structure of the organization, including main divisions,
operating companies, subsidiaries, and joint ventures.
Form 20-F 2012 – Part I - Item 4
- (http://en.sanofi.com/investors/
news/news.aspx)
19 & 83
2.4
Location of organization’s headquarters.
Paris
2.5
Number of countries where the organization operates, and names
of countries with either major operations or that are specifically
relevant to the sustainability issues covered in the report.
2012 CSR Report – Introduction,
Group profile
2
2.6
Nature of ownership and legal form.
Form 20-F 2012 – Part I - Item 4
- (http://en.sanofi.com/investors/
news/news.aspx), Sanofi Share
(http://en.sanofi.com/investors/
share/share.aspx)
21
2.7
Markets served (including geographic breakdown, sectors served,
and types of customers/beneficiaries).
2012 CSR Report – Introduction,
Group profile
2
2.8
Scale of the reporting organization.
2012 CSR Report – Introduction,
Group profile
2
Form 20-F 2012 – Part I - Item 4
- (http://en.sanofi.com/investors/
news/news.aspx)
2, 24 &
25
2012 CSR Report – Our CSR
performance, Reporting
methodology
94
2.9
Significant changes during the reporting period regarding size,
structure, or ownership.
Front
cover
2
GLOBAL REPORTING INITIATIVE
Profile
disclosure
Disclosure
2.10
Awards received in the reporting period.
Level of
reporting
Location of disclosure
Page
2012 CSR Report – Our CSR
performance, Statutory auditors’
report
96
Download Center – 2012 External
CSR awards received factsheet
3. Report parameters
3.1
Reporting period (e.g., fiscal/calendar year) for information
provided.
2012 CSR Report – Our CSR
performance, Reporting
methodology
3.2
Date of most recent previous report (if any).
2011
3.3
Reporting cycle (annual, biennial, etc).
Annually
3.4
Contact point for questions regarding the report or its contents.
[email protected]
3.5
Process for defining report content.
2012 CSR Report – Introduction,
Our material issues
7
2012 CSR Report – Introduction,
Stakeholder relations
8
94
Back
cover
3.6
Boundary of the report (e.g., countries, divisions, subsidiaries, leased
facilities, joint ventures, suppliers). See GRI Boundary Protocol for
further guidance.
2012 CSR Report – Introduction,
Reporting methodology
94
3.7
State any specific limitations on the scope or boundary of the
report (see completeness principle for explanation of scope).
2012 CSR Report – Introduction,
Reporting methodology
94
3.8
Basis for reporting on joint ventures, subsidiaries, leased facilities,
outsourced operations, and other entities that can significantly
affect comparability from period to period and/or between
organizations.
2012 CSR Report – Introduction,
Reporting methodology
94
3.9
Data measurement techniques and the bases of calculations,
including assumptions and techniques underlying estimations
applied to the compilation of the Indicators and other information
in the report. Explain any decisions not to apply, or to substantially
diverge from, the GRI Indicator Protocols.
2012 CSR Report – Introduction,
Reporting methodology
94
3.10
Explanation of the effect of any re-statements of information
provided in earlier reports, and the reasons for such re-statement
(e.g., mergers/acquisitions, change of base years/periods, nature
of business, measurement methods).
2012 CSR Report – Introduction,
Reporting methodology
94
3.11
Significant changes from previous reporting periods in the scope,
boundary, or measurement methods applied in the report.
2012 CSR Report – Introduction,
Reporting methodology
94
3.12
Table identifying the location of the Standard Disclosures in
the report.
2012 CSR Report – Our CSR
performance, Global reporting
initiative
91
Policy and current practice with regard to seeking external
assurance for the report.
2012 CSR Report – Our CSR
performance, Statutory auditors’
report
97
3.13
4. Governance, commitments and engagement
4.1
Governance structure of the organization, including committees
under the highest governance body responsible for specific tasks,
such as setting strategy or organizational oversight.
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
4.2
Indicate whether the Chair of the highest governance body is also
an executive officer.
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
150
4.3
For organizations that have a unitary board structure, state the
number and gender of members of the highest governance body
that are independent and/or non-executive members.
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
150-167
150-167
3
GLOBAL REPORTING INITIATIVE
Profile
disclosure
Disclosure
4.4
Mechanisms for shareholders and employees to provide
recommendations or direction to the highest governance body.
4.5
Linkage between compensation for members of the highest
governance body, senior managers, and executives (including
departure arrangements), and the organization's performance
(including social and environmental performance).
Level of
reporting
Location of disclosure
Page
2012 CSR Report – Introduction,
Stakeholder relations
8
Form 20-F 2012 – Part I - Item 6,
– Part I - Item 7, – Part I - Item 10,
- (http://en.sanofi.com/investors/
news/news.aspx).
181-182
194
210-211
2012 CSR Report – Senior
management interview
3
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
150-167
As part of the annual appraisal
process executives and senior
managers are measured
against Sanofi’s performance.
Some executives and senior
managers, directly involved in
health, safety and environment
and CSR, are measured against
the relevant environmental and
social performance. This has an
impact on their compensation
agreements. Business performance
is also considered in compensation
for all employees. Increasing
female talent is now part of the
bonus objectives of the Executive
Committee.
4.6
Processes in place for the highest governance body to ensure
conflicts of interest are avoided.
Form 20-F 2012 – Part II - Item 15 &
16 - (http://en.sanofi.com/investors/
news/news.aspx)
242-243
4.7
Process for determining the composition, qualifications, and
expertise of the members of the highest governance body and
its committees, including any consideration of gender and other
indicators of diversity.
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
150-167
4.8
Internally developed statements of mission or values, codes of
conduct, and principles relevant to economic, environmental, and
social performance and the status of their implementation.
Download Center – Policies and
management systems factsheet
Procedures of the highest governance body for overseeing the
organization's identification and management of economic,
environmental, and social performance, including relevant
risks and opportunities, and adherence or compliance with
internationally agreed standards, codes of conduct, and principles.
2012 CSR Report – CSR
Governance
4.9
Download Center – Responsible
lobbying factsheet
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
4.10
Processes for evaluating the highest governance body's
own performance, particularly with respect to economic,
environmental, and social performance.
Form 20-F 2012 – Part I - Item 6
- (http://en.sanofi.com/investors/
news/news.aspx)
4.11
Explanation of whether and how the precautionary approach or
principle is addressed by the organization.
Download Center – Energy carbon
footprint factsheet
Download Center – Risk
management factsheet
4.12
Externally developed economic, environmental, and social
charters, principles, or other initiatives to which the organization
subscribes or endorses.
9
CSR Governance. The Senior VP
of CSR presents to and discusses
CSR issues with the Board on an
annual basis.
Download Center – Policies and
management systems factsheet
Download Center – Human rights
factsheet
182
150-167
4
GLOBAL REPORTING INITIATIVE
Profile
disclosure
Disclosure
Level of
reporting
Location of disclosure
4.13
Memberships in associations (such as industry associations) and/or
national/international advocacy organizations in which the
organization: has positions in governance bodies; participates
in projects or committees; provides substantive funding beyond
routine membership dues; or views membership as strategic.
Download Center – Corporate
governance factsheet
4.14
List of stakeholder groups engaged by the organization.
Download Center – Stakeholder
engagement factsheet
4.15
Basis for identification and selection of stakeholders with whom
to engage.
Download Center – Stakeholder
engagement factsheet
4.16
Approaches to stakeholder engagement, including frequency of
engagement by type and by stakeholder group.
Download Center – Stakeholder
engagement factsheet
4.17
Key topics and concerns that have been raised through
stakeholder engagement, and how the organization has
responded to those key topics and concerns, including through
its reporting.
Download Center – Stakeholder
engagement factsheet
Download Center – Memberships &
collaboration factsheet
Download Center – Partnering with
patient associations factsheet
Download Center – CSR approach
and governance factsheet
Responsible Lobbying and
Pharmaceuticals in the
environment became CSR priorities
in our strategy and reporting
following increasing interest
from our stakeholders for these
topics. SRI investors also asked for
more information about our CSR
activities, therefore we held a CSR
Investor meeting in 2012 see: http://
en.sanofi.com/investors/events/
corporate/2012/2012-12-17_IR_
seminar_CSR.aspx
Page
5
GLOBAL REPORTING INITIATIVE
Standard disclosures part ii: Disclosures on Management Approach (DMAs)
Disclosure
Level of
reporting
Location of disclosure
Page
Economic
performance
Chapter 4, document reference, Form 20-F 2012 – Part I - Item 5 (http://en.sanofi.com/investors/news/news.aspx)
90-91
Market presence
Chapter 4, document reference, Form 20-F 2012 – Part I - Item 5 (http://en.sanofi.com/investors/news/news.aspx)
90-91
Indirect
economic
impacts
Chapter 4, document reference
Further comments
Economic
2012 CSR Report – People, Workforce development
66
Download Center – Workforce_Development
Environment
Materials
Download Center – HSE policy factsheet
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
Download Center – Green chemistry factsheet
Download Center – HSE management system factsheet
Energy
Download Center – HSE policy factsheet
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
Download Center – Energy carbon footprint factsheet
Download Center – HSE management system factsheet
Water
Download Center – HSE policy factsheet
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
Download Center – Water management factsheet
Download Center – HSE management system factsheet
Biodiversity
2012 CSR Report – Planet, Pharmaceuticals in the environment
81
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
78
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
81
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
81
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
71
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
Download Center – HSE policy factsheet
Download Center – Sanofi Position on biodiversity and
biopiracy factsheet
Download Center – HSE management system factsheet
Emissions,
effluents and
waste
2012 CSR Report – Planet, Water management
Download Center – HSE policy factsheet
Download Center – Energy carbon footprint factsheet
Download Center – Quality management system factsheet
Download Center – Waste management factsheet/Policy/ Position
Download Center – Protection of the atmosphere factsheet/ Policy/
Position
Download Center – HSE management system factsheet/
Policy/Position
Products and
services
2012 CSR Report – Planet, Pharmaceuticals in the environment
Download Center – HSE policy factsheet
Download Center – HSE management system factsheet
Compliance
2012 CSR Report – Planet, Pharmaceuticals in the environment
Download Center – HSE policy factsheet
Download Center – Protection of the atmosphere factsheet
Download Center – HSE management system factsheet
Transport
2012 CSR Report – Planet, Energy and carbon footprint
Download Center – HSE policy factsheet
6
GLOBAL REPORTING INITIATIVE
Disclosure
Overall
Level of
reporting
Location of disclosure
Page
Further comments
2012 CSR Report – Planet, Energy and carbon footprint
71
2012 CSR Report – Planet, Water management
78
Organizational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
Download Center – HSE policy factsheet
Labour practices and decent work
Employment
2012 CSR Report – People, Workforce development
Labor/
management
relations
Download Center – Employee representation and information
factsheet
Occupational
health and safety
2012 CSR Report – People, Health and safety in the workplace
Training and
education
Download Center – Human rights factsheet
Diversity and
equal opportunity
Download Center – Les enfants de Sanofi factsheet
Organizational responsibility
sits with the Senior VP in CSR,
reporting to the CEO
Equal
remuneration for
women and men
Download Center – Les enfants de Sanofi factsheet
Organisations responsibility
sits with the Senior VP of
Human Resources, reporting
to the CEO
66
Organizational responsibility
sits with the Senior VP of
Human Resources, reporting
to the CEO
56
Download Center – HSE policy factsheet
2012 CSR Report – People, Workforce development
66
Human rights
Investment and
procurement
practices
2012 CSR Report – Ethics, Human rights
Nondiscrimination
2012 CSR Report – Ethics, Human rights
50
Download Center – Responsible procurement factsheet
50
Download Center – Responsible procurement factsheet
Download Center – Suppliers code of conduct factsheet
Freedom of
association
and collective
bargaining
2012 CSR Report – Ethics, Human rights
50
Download Center – Responsible procurement factsheet
Download Center – Suppliers code of conduct factsheet
Registation Document 2012 – Section 4.1.3 - page 11 (http://en.sanofi.com/investors/news/news.aspx)
Child labor
2012 CSR Report – Ethics, Human rights
50
Download Center – Responsible procurement factsheet
Download Center – Suppliers code of conduct factsheet
Prevention of
forced and
compulsory labor
2012 CSR Report – Ethics, Human rights
Download Center – Responsible procurement factsheet
Download Center – Suppliers code of conduct factsheet
Organizational responsibility
sits with the Senior VP of
Human Resources, reporting
to the CEO
50
Organisational responsibility
sits with the Head of HSE
reporting to the Senior Vice
President of Corporate
Affairs, reporting to the CEO
Organisational responsibility
sits with the Senior VP of
Human Resources, reporting
to the CEO
7
GLOBAL REPORTING INITIATIVE
Disclosure
Level of
reporting
Location of disclosure
Page
Security practices
The Corporate Economic Security Direction has established a policy
for protection of its employees based on identification and analysis
of risks, informing employees, monitoring of business travellers
movements, training of employees, local expatriates and business
travellers, the implementation of assistance plans, particularly in atrisk countries. The people protection department, responsible for the
implementation of this policy, defines the objectives and establishes
the resources to ensure this global protection.
Indigenous rights
Download Center – Sanofi position on biodiversity and
biopiracy factsheet
Assessment
2012 CSR Report – Ethics, Human rights, Supplier evaluations,
Procurement
54
Remediation
2012 CSR Report – Ethics, Human rights, Supplier evaluations,
Procurement
54
Local
communities
2012 CSR Report – Patient, Access to healthcare, Sanofi Espoir
Foundation
16
Corruption
2012 CSR Report – Ethics, Business ethics, Responsible marketing
46
2012 CSR Report – Ethics, Business ethics, Responsible lobbying
43
Further comments
Society
The approach the
local communities is
decentralised and is the
responsibility of the General
Manager at local level.
Download Center – Sanofi Supplier Relationships Charter factsheet
Public policy
2012 CSR Report – Ethics, Business ethics, Responsible lobbying
43
Anti-competitive
behavior
2012 CSR Report – Ethics, Business ethics, Responsible lobbying
43
Compliance
2012 CSR Report – Ethics, Business ethics, Responsible lobbying
43
2012 CSR Report – Patient, Patient safety, Drug safety monitoring
30
2012 CSR Report – Patient, Patient safety, Product quality
33
Product responsibility
Customer health
and safety
Download Center – Global quality policy
Product and
service labelling
Marketing
communications
2012 CSR Report – Patient, Patient safety, Product quality
33
Download Center – Global quality policy
2012 CSR Report – Ethics, Business ethics, Responsible marketing
46
2012 CSR Report – Patient, Patient safety, Product quality
33
Download Center – Global quality policy
2012 CSR Report – Ethics, Business ethics, Responsible marketing
Customer privacy
Data protection charter, FAQ about Clinical Trials
Compliance
2012 CSR Report – Patient, Patient safety, Product quality
46
We follow good clinical
practises in line with the
Helsinki declaration.
33
8
GLOBAL REPORTING INITIATIVE
Standard disclosures part iii: performance indicators
Indicator
Disclosure
Level of
reporting
Location of disclosure
Page
Direct economic value generated and distributed, including
revenues, operating costs, employee compensation, donations
and other community investments, retained earnings, and
payments to capital providers and governments.
Form 20-F 2012 – Part I - Item 3
- (http://en.sanofi.com/investors/
news/news.aspx)
2
Financial implications and other risks and opportunities for the
organization’s activities due to climate change.
Download Center – Energy carbon
footprint factsheet
Economic
Economic performance
EC1
EC2
Download Center – Risk
management system factsheet
EC3
Coverage of the organization’s defined benefit plan obligations.
Form 20-F 2012 – Part I - Item 4
- (http://en.sanofi.com/investors/
news/news.aspx)
31
Market presence
EC6
Policy, practices, and proportion of spending on locally-based
suppliers at significant locations of operation.
Registation document 2012 –
Section 4.3.3 – (http://en.sanofi.
com/investors/news/news.aspx)
366
361
Indirect economic impacts
EC8
Development and impact of infrastructure investments and
services provided primarily for public benefit through commercial,
in-kind, or pro bono engagement.
Registation Document 2012 –
Section 4.3.1 – (http://en.sanofi.
com/investors/news/news.aspx)
EC9
Understanding and describing significant indirect economic
impacts, including the extent of impacts.
2012 CSR Report – Patient, Access
to healthcare
13
Environmental
Materials
EN1
Materials used by weight or volume.
2012 CSR Report – Our CSR
performance, Our indicators
89
EN2
Percentage of materials used that are recycled input materials.
2012 CSR Report – Our CSR
performance, Our indicators
89
EN3
Direct energy consumption by primary energy source.
2012 CSR Report – Our CSR
performance, Our indicators
89
EN4
Indirect energy consumption by primary source.
2012 CSR Report – Our CSR
performance, Our indicators
89
EN7
Initiatives to reduce indirect energy consumption and
reductions achieved.
2012 CSR Report – Planet, Energy
and carbon footprint
71
EN8
Total water withdrawal by source.
2012 CSR Report – Our CSR
performance, Our indicators
89
EN9
Water sources significantly affected by withdrawal of water.
2012 CSR Report – Planet, Water
management
78
Energy
Water
9
GLOBAL REPORTING INITIATIVE
Indicator
Disclosure
Level of
reporting
Location of disclosure
Page
Biodiversity
Location and size of land owned, leased, managed in, or adjacent
to, protected areas and areas of high biodiversity value outside
protected areas.
Download Center – Biodiversity and
biopiracy factsheet
EN12
Description of significant impacts of activities, products, and
services on biodiversity in protected areas and areas of high
biodiversity value outside protected areas.
2012 CSR Report – Planet,
Pharmaceuticals in the environment
EN13
Habitats protected or restored.
Download Center – Sanofi position on
biodiversity and biopiracy factsheet
EN14
Strategies, current actions, and future plans for managing impacts
on biodiversity.
Download Center – Sanofi position on
biodiversity and biopiracy factsheet
EN15
Number of IUCN Red List species and national conservation list
species with habitats in areas affected by operations, by level of
extinction risk.
2012 CSR Report – Our CSR
performance, Our indicators
EN11
Three of the Group’s industrial sites,
Swiftwater (US), Vertolaye (France),
and Csanyikvolgy (Hungary),
are located in environmentally
protected zones/areas where
environmental regulations are more
stringent in order to preserve the
natural resources surrounding these
sites. They are under particular
scrutiny as a result of their location.
81
90
Download Center – Sanofi position on
biodiversity and biopiracy factsheet
Emissions, effluents and waste
EN16
Total direct and indirect greenhouse gas emissions by weight.
2012 CSR Report – Our CSR
performance, Our indicators
90
EN17
Other relevant indirect greenhouse gas emissions by weight.
2012 CSR Report – Our CSR
performance, Our indicators
90
EN18
Initiatives to reduce greenhouse gas emissions and
reductions achieved.
2012 CSR Report – Planet, Energy
and carbon footprint
71
EN19
Emissions of ozone-depleting substances by weight.
This is <1 tonne. A more precise
figure is not relevant as it has such
a minor impact.
EN20
NOx, SOx, and other significant air emissions by type and weight.
2012 CSR Report – Our CSR
performance, Our indicators
90
EN21
Total water discharge by quality and destination.
2012 CSR Report – Planet, Water
management
78
2012 CSR Report – Our CSR
performance, Our indicators
90
90
EN22
Total weight of waste by type and disposal method.
2012 CSR Report – Our CSR
performance, Our indicators
EN23
Total number and volume of significant spills.
Number of uncontrolled
environmental releases to air land
or water resulting in information to
local authorities
4 in 2010
0 in 2011
6 in 2012
Products and services
EN26
Initiatives to mitigate environmental impacts of products and
services, and extent of impact mitigation.
2012 CSR Report – Planet,
Pharmaceuticals in the environment
81
2012 CSR Report – Our CSR
performance, Our indicators
90
10
GLOBAL REPORTING INITIATIVE
Indicator
Disclosure
Level of
reporting
Location of disclosure
Page
Compliance
EN28
Monetary value of significant fines and total number of nonmonetary sanctions for non-compliance with environmental laws
and regulations.
The monetary value of fines and
total number of non-monetary
sanctions for non-compliance with
environmental laws and regulations
is not significant.
Significant environmental impacts of transporting products and
other goods and materials used for the organization’s operations,
and transporting members of the workforce.
2012 CSR Report – Planet, Energy
and carbon footprint
71
2012 CSR Report – Our CSR
performance, Our indicators
90
2012 CSR Report – Our CSR
performance, Our indicators
90
Transport
EN29
Overall
EN30
Total environmental protection expenditures and investments
by type.
Social: Labor Practices and Decent Work
Employment
LA1
Total workforce by employment type, employment contract, and
region, broken down by gender.
Registation Document 2012 –
Section 4.1.1 – (http://en.sanofi.
com/investors/news/news.aspx)
331
LA2
Total number and rate of new employee hires and employee
turnover by age group, gender, and region.
Registation Document 2012 –
Section 4.1.1 – (http://en.sanofi.
com/investors/news/news.aspx)
331
Registation Document 2012 –
Section 4.1.3 – (http://en.sanofi.
com/investors/news/news.aspx)
340
Rates of injury, occupational diseases, lost days, and absenteeism,
and number of work-related fatalities by region and by gender.
Registation Document 2012 –
Section 4.1.4 – (http://en.sanofi.
com/investors/news/news.aspx)
343
Education, training, counseling, prevention, and risk-control
programs in place to assist workforce members, their families, or
community members regarding serious diseases.
Need to include the table from the
guidelines to be ‘fully’
Labor/management relations
LA4
Percentage of employees covered by collective bargaining
agreements.
Occupational health and safety
LA7
LA8
Training and education
LA10
Average hours of training per year per employee by gender, and
by employee category.
2012 CSR Report – Our CSR
performance, Our indicators
87
LA11
Programs for skills management and lifelong learning that support
the continued employability of employees and assist them in
managing career endings.
2012 CSR Report – People,
Workforce development
66
LA12
Percentage of employees receiving regular performance and
career development reviews, by gender.
2012 CSR Report – People,
Workforce development
66
100% of employees of both
genders receive annual
performance reviews.
Diversity and equal opportunity
LA13
Composition of governance bodies and breakdown of employees
per employee category according to gender, age group, minority
group membership, and other indicators of diversity.
2012 CSR Report – People, Diversity
As a French company we are
not allowed to collect ethnicity
data but we do collect it at US
affiliate level.
60
11
GLOBAL REPORTING INITIATIVE
Indicator
Disclosure
Level of
reporting
Location of disclosure
Page
Social: Human Rights
Investment and procurement practices
HR1
Percentage and total number of significant investment agreements
and contracts that include clauses incorporating human rights
concerns, or that have undergone human rights screening.
Download Center – Responsible
procurement factsheet
HR2
Percentage of significant suppliers, contractors and other business
partners that have undergone human rights screening, and
actions taken.
2012 CSR Report – Ethics,
Human rights
50
100% of our suppliers and
contractors receive our supplier
code of conduct which includes
human rights aspects.
In 2012 354 suppliers were
identified to undergo CSR
evaluation and 18% (65) had to
implement corrective action plans.
HR3
Total hours of employee training on policies and procedures
concerning aspects of human rights that are relevant to operations,
including the percentage of employees trained.
8 hours per employee
2012 CSR Report – Ethics,
Human rights
50
2012 CSR Report – Our CSR
performance, Our indicators
87
Non-discrimination
HR4
Total number of incidents of discrimination and actions taken.
Freedom of association and collective bargaining
HR5
Operations and significant suppliers identified in which the right to
exercise freedom of association and collective bargaining may be
violated or at significant risk, and actions taken to support
these right.
A risk analysis of suppliers has been
performed. ECOVADIS is used on
the suppliers and in the countries of
operaton identified as high risk.
Operations and significant suppliers identified as having significant
risk for incidents of child labor, and measures taken to contribute to
the effective abolition of child labor.
A risk analysis of suppliers has been
performed. ECOVADIS is used on
the suppliers and in the countries of
operaton identified as high risk.
Child labor
HR6
Forced and compulsory labor
HR7
Operations and significant suppliers identified as having significant
risk for incidents of forced or compulsory labor, and measures to
contribute to the elimination of all forms of forced or compulsory
labor.
A risk analysis of suppliers has been
performed. ECOVADIS is used on
the suppliers and in the countries of
operaton identified as high risk.
Percentage and total number of operations that have been
subject to human rights reviews and/or impact assessments.
More than 7 functions have
been subject to Human Rights
assessment at corporate and local
level (legal, human resources,
security, R&D, Public Affairs, Supply
Chain, Pharmacovigilance,
Marketing, etc).
Assessment
HR10
Social: Society
Local communities
SO1
Percentage of operations with implemented local community
engagement, impact assessments, and development programs.
2012 CSR Report – Patient, Access
to healthcare
13
Percentage of employees trained in organization's anti-corruption
policies and procedures.
2012 CSR Report – Ethics, Business
ethics, Responsible lobbying
43
2012 CSR Report – Our CSR
Performance, Our indicators
87
Corruption
SO3
12
GLOBAL REPORTING INITIATIVE
Indicator
Disclosure
Level of
reporting
Location of disclosure
Page
2012 CSR Report – Ethics, Business
ethics, Responsible lobbying
43
Total number of legal actions for anti-competitive behavior, antitrust, and monopoly practices and their outcomes.
Form 20-F 2012 – Part I - Item 8
- (http://en.sanofi.com/investors/
news/news.aspx)
198-201
Monetary value of significant fines and total number of nonmonetary sanctions for non-compliance with laws and regulations.
Form 20-F 2012 – Part I - Item 8
- (http://en.sanofi.com/investors/
news/news.aspx)
198-201
30
Public policy
SO5
Public policy positions and participation in public policy
development and lobbying.
Anti-competitive behavior
SO7
Compliance
SO8
Social: Product Responsibility
Customer health and safety
PR1
Life cycle stages in which health and safety impacts of products
and services are assessed for improvement, and percentage
of significant products and services categories subject to such
procedures.
2012 CSR Report – Patient, Patient
safety, Drug safety monitoring
PR2
Total number of incidents of non-compliance with regulations and
voluntary codes concerning health and safety impacts of products
and services during their life cycle, by type of outcomes.
2012 CSR Report – Ethics, Ethics in
R&D - Clinical trials
38
Product and service labelling
PR3
Type of product and service information required by procedures,
and percentage of significant products and services subject to
such information requirements.
2012 CSR Report – Ethics, Business
ethics, Responsible marketing
46
PR5
Practices related to customer satisfaction, including results of
surveys measuring customer satisfaction.
2012 CSR Report – Patient, Patient
safety, Product quality
33
2012 CSR Report – Ethics, Business
ethics, Responsible marketing
46
Marketing communications
PR6
Programs for adherence to laws, standards, and voluntary codes
related to marketing communications, including advertising,
promotion, and sponsorship.

Documents pareils